Correlation Between Effector Therapeutics and Silo Pharma
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Silo Pharma, you can compare the effects of market volatilities on Effector Therapeutics and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Silo Pharma.
Diversification Opportunities for Effector Therapeutics and Silo Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Effector and Silo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Silo Pharma go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Silo Pharma
If you would invest 89.00 in Silo Pharma on December 29, 2024 and sell it today you would earn a total of 36.00 from holding Silo Pharma or generate 40.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Effector Therapeutics vs. Silo Pharma
Performance |
Timeline |
Effector Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Silo Pharma |
Effector Therapeutics and Silo Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and Silo Pharma
The main advantage of trading using opposite Effector Therapeutics and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Silo Pharma vs. Rezolute | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited | Silo Pharma vs. Inventiva Sa |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |